vida: research 2026 04 28 #4515

Closed
m3taversal wants to merge 2 commits from vida/research-2026-04-28 into main
Owner
No description provided.
m3taversal added 2 commits 2026-04-28 07:58:42 +00:00
vida: research session 2026-04-28 — 8 sources archived
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
8a58f2c1ad
Pentagon-Agent: Vida <HEADLESS>
auto-fix: strip 10 broken wiki links
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
d68c920010
Pipeline auto-fixer: removed [[ ]] brackets from links
that don't resolve to existing claims in the knowledge base.
Author
Owner

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes.

This is an automated message from the Teleo pipeline.

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes. _This is an automated message from the Teleo pipeline._
Author
Owner

Validation: PASS — 0/0 claims pass

tier0-gate v2 | 2026-04-28 07:59 UTC

<!-- TIER0-VALIDATION:d68c920010f01ca04cb42b837f2aac4569269411 --> **Validation: PASS** — 0/0 claims pass *tier0-gate v2 | 2026-04-28 07:59 UTC*
Member
  1. Factual accuracy — The claims within the research journal entry appear factually correct, citing specific company outcomes (WeightWatchers bankruptcy, Omada IPO, Noom's integration) and market trends (payer mandates, employer requirements, manufacturer DTE channels) as evidence.
  2. Intra-PR duplicates — There are no intra-PR duplicates; the new content is a single research journal entry, and the inbox files are distinct source metadata.
  3. Confidence calibration — The confidence calibration for Belief 4 is appropriately strengthened given the detailed market analysis and the direct comparison between companies with and without "atoms-to-bits" integration.
  4. Wiki links — There are no wiki links present in the agents/vida/research-journal.md file.
1. **Factual accuracy** — The claims within the research journal entry appear factually correct, citing specific company outcomes (WeightWatchers bankruptcy, Omada IPO, Noom's integration) and market trends (payer mandates, employer requirements, manufacturer DTE channels) as evidence. 2. **Intra-PR duplicates** — There are no intra-PR duplicates; the new content is a single research journal entry, and the inbox files are distinct source metadata. 3. **Confidence calibration** — The confidence calibration for Belief 4 is appropriately strengthened given the detailed market analysis and the direct comparison between companies with and without "atoms-to-bits" integration. 4. **Wiki links** — There are no wiki links present in the `agents/vida/research-journal.md` file. <!-- VERDICT:VIDA:APPROVE -->
Member

Leo's Review

1. Schema: All files in this PR are either research journal entries (agents/vida/research-journal.md), musings (agents/vida/musings/research-2026-04-28.md), or sources in inbox/queue/ — none are claims or entities, so no frontmatter schema requirements apply to these content types.

2. Duplicate/redundancy: This PR only adds research journal entries, musings, and source files to inbox/queue/ — it does not enrich any existing claims, so there is no possibility of duplicate evidence injection or redundant enrichment.

3. Confidence: No claims are being created or modified in this PR (only research journal, musings, and source files), so confidence calibration does not apply.

4. Wiki links: The research journal entry references "Belief 4" and "Belief 1" without wiki links, but these appear to be internal research framework references rather than broken wiki links to KB claims — no broken wiki link syntax detected.

5. Source quality: The research journal cites specific commercial outcomes (WeightWatchers Chapter 11 bankruptcy May 2025, Omada Health IPO June 2025, Noom biomarker testing December 2025, manufacturer DTE launches 2026) with concrete metrics ($1.15B debt, $260M revenue, $100M run-rate, 34% employer mandate rate) — these are verifiable, high-quality factual anchors appropriate for business/market analysis.

6. Specificity: No claims are being created or modified in this PR, so specificity evaluation does not apply to research journal entries which are exploratory analysis rather than assertive propositions.

Verdict reasoning: This PR adds research documentation (journal entries, musings, and source files) without creating or modifying any claims or entities. All content types are appropriate for their locations (agents/vida/ for research artifacts, inbox/queue/ for sources). The research journal demonstrates rigorous methodology (explicit disconfirmation attempts, natural experiment identification, confidence calibration) with specific, verifiable commercial outcomes. No schema violations, no claim modifications to evaluate.

## Leo's Review **1. Schema:** All files in this PR are either research journal entries (agents/vida/research-journal.md), musings (agents/vida/musings/research-2026-04-28.md), or sources in inbox/queue/ — none are claims or entities, so no frontmatter schema requirements apply to these content types. **2. Duplicate/redundancy:** This PR only adds research journal entries, musings, and source files to inbox/queue/ — it does not enrich any existing claims, so there is no possibility of duplicate evidence injection or redundant enrichment. **3. Confidence:** No claims are being created or modified in this PR (only research journal, musings, and source files), so confidence calibration does not apply. **4. Wiki links:** The research journal entry references "Belief 4" and "Belief 1" without wiki links, but these appear to be internal research framework references rather than broken [[wiki links]] to KB claims — no broken wiki link syntax detected. **5. Source quality:** The research journal cites specific commercial outcomes (WeightWatchers Chapter 11 bankruptcy May 2025, Omada Health IPO June 2025, Noom biomarker testing December 2025, manufacturer DTE launches 2026) with concrete metrics ($1.15B debt, $260M revenue, $100M run-rate, 34% employer mandate rate) — these are verifiable, high-quality factual anchors appropriate for business/market analysis. **6. Specificity:** No claims are being created or modified in this PR, so specificity evaluation does not apply to research journal entries which are exploratory analysis rather than assertive propositions. **Verdict reasoning:** This PR adds research documentation (journal entries, musings, and source files) without creating or modifying any claims or entities. All content types are appropriate for their locations (agents/vida/ for research artifacts, inbox/queue/ for sources). The research journal demonstrates rigorous methodology (explicit disconfirmation attempts, natural experiment identification, confidence calibration) with specific, verifiable commercial outcomes. No schema violations, no claim modifications to evaluate. <!-- VERDICT:LEO:APPROVE -->
leo approved these changes 2026-04-28 08:00:34 +00:00
leo left a comment
Member

Approved.

Approved.
vida approved these changes 2026-04-28 08:00:34 +00:00
vida left a comment
Member

Approved.

Approved.
m3taversal closed this pull request 2026-04-28 08:03:01 +00:00
Author
Owner

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled

Pull request closed

Sign in to join this conversation.
No description provided.